$NTLA

$12.28 +$1.02 (9.06%) Close

$NTLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NTLA Management Team

Dr. Frank Verwiel

Independent Chairman of the Board

Age 62

Compensation $499.9K USD

Sex Male

Dr. John Leonard

President

Chief Executive Officer

Director

Age 67

Compensation $15.33M USD

Sex Male

Mr. Edward Dulac

Chief Financial Officer

Executive Vice President

Treasurer

Age 50

Compensation $6.695M USD

Sex Male

Ms. Eliana Clark

Executive Vice President

Chief Technology Officer

Age 68

Compensation -

Sex Female

Dr. Birgit Schultes

Executive Vice President

Chief Scientific Officer

Age 62

Compensation -

Sex Female

Mr. James Basta

Executive Vice President

General Counsel

Corporate Secretary

Age 59

Compensation $4.873M USD

Sex Male

Dr. David Lebwohl

Executive Vice President

Chief Medical Officer

Age 70

Compensation $5.577M USD

Sex Male

Mr. Michael Dube

Chief Accounting Officer

Vice President

Age 47

Compensation $1.343M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Frank Verwiel Independent Chairman of the Board	62	$499.9K USD	Male
Dr. John Leonard President Chief Executive Officer Director	67	$15.33M USD	Male
Mr. Edward Dulac Chief Financial Officer Executive Vice President Treasurer	50	$6.695M USD	Male
Ms. Eliana Clark Executive Vice President Chief Technology Officer	68	-	Female
Dr. Birgit Schultes Executive Vice President Chief Scientific Officer	62	-	Female
Mr. James Basta Executive Vice President General Counsel Corporate Secretary	59	$4.873M USD	Male
Dr. David Lebwohl Executive Vice President Chief Medical Officer	70	$5.577M USD	Male
Mr. Michael Dube Chief Accounting Officer Vice President	47	$1.343M USD	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

6.2 years

from year joined

CEO also chairs the board

Frank Verwiel, M.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Muna Bhanji	63	2022 4 years	Independent	Audit Committee Compensation and Talent Development Committee Science and Technology Committee	Cytokinetics, Inc., Veracyte, Inc., Ardelyx, Inc.	Not stated
Brian Goff	57	2024 2 years	Independent	Nominating and Corporate Governance Committee	Agios Pharmaceuticals, Inc.	$196,440
Jesse Goodman, M.D., M.P.H.	74	2018 8 years	Independent	None stated	None stated	$197,700
Fred Cohen, M.D., D.Phil.	69	2019 7 years	Independent	None stated	CareDx, Inc., Kyverna Therapeutics, Inc.	$192,700
Frank Verwiel, M.D. Board chair	63	2017 9 years	Independent	Audit Committee	Bavarian Nordic A/S	$232,700
William Chase	58	2023 3 years	Independent	Compensation and Talent Development Committee	Parexel International Corporation, Grail, Inc.	$205,200
Georgia Keresty, Ph.D., M.P.H.	64	2021 5 years	Independent	None stated	Solid Biosciences, Inc.	$200,200
John M. Leonard CEO, Executive officer	68	2014 12 years	Not independent	None stated	IQVIA Holdings Inc.	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$NTLA Management Team

Dr. Frank Verwiel

Dr. John Leonard

Mr. Edward Dulac

Ms. Eliana Clark

Dr. Birgit Schultes

Mr. James Basta

Dr. David Lebwohl

Mr. Michael Dube

Board of Directors

Related-party transactions

No related-party transactions disclosed